Apr 29, 2016 05:39 am UTC| Business
Royalty revenue to Zealand from Sanofi's sales of Lyxumia(r) (lixisenatide) amounted to DKK 6.5 million / EUR 0.9 million in Q1 2016 In March 2016, Sanofi submitted as planned the fixed-ratio combination of basal...
REXEL :Q1 2016 RESULTS (unaudited)
Apr 29, 2016 05:36 am UTC| Business
Q1 2016 RESULTS (unaudited) SEQUENTIAL IMPROVEMENT IN SALES RESILIENT PROFITABILITY FULL-YEAR FINANCIAL TARGETS CONFIRMED PARIS, April 29, 2016 -- SEQUENTIAL IMPROVEMENT IN SALES Sequential improvement in...
Galapagos and AbbVie expand their cystic fibrosis collaboration
Apr 29, 2016 05:05 am UTC| Business
Strong commitment from Galapagos and AbbVie to accelerate development of a triple combination therapy Expanded portfolio shows promise for breakthrough therapy Milestones increased from $350 to $600...
ABLYNX ANNOUNCES MILESTONE IN DRUG DISCOVERY COLLABORATION
Apr 29, 2016 05:05 am UTC| Business
Second Nanobody targeting a G-protein-coupled receptor (GPCR) enters clinical development Further positive validation of Ablynx's Nanobody platform and its ability to address complex targets that have proven to be...
Apr 28, 2016 22:36 pm UTC| Business
WASHINGTON, April 28, 2016 -- Today at the 36th Annual International Society for Heart and Lung Transplantation (ISHLT) Meeting Scientific Sessions, researchers from the Universities of Calgary and Alberta in Canada...
Gemalto first quarter 2016 revenue
Apr 28, 2016 22:02 pm UTC| Business
Revenue at €691 million, up +1% at historical exchange rates and flat at constant exchange rates Strong head start in Government Programs, Machine-to-Machine, Enterprise and Payment fully offsets softer markets...
Apr 28, 2016 21:35 pm UTC| Business
MONTROUGE, France, April 28, 2016 -- DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage specialty biopharmaceutical company, today announced the filing of its 2015 Annual...